Human placental extract offers protection against experimental visceral leishmaniasis: a pilot study for a phase-I clinical trial.

Chakraborty, D and Basu, J M and Sen, Pradip and Sundar, S and Roy, S (2008) Human placental extract offers protection against experimental visceral leishmaniasis: a pilot study for a phase-I clinical trial. Annals of tropical medicine and parasitology, 102 (1). pp. 21-38. ISSN 0003-4983

PDF sen2008.1.pdf - Published Version Restricted to Registered users only Download (466Kb) | Request a copy

Abstract

An aqueous extract of human placenta (HPE) was found to offer protection against established experimental visceral leishmaniasis in BALB/c mice and hamsters, whether the Leishmania donovani strain involved was one that was sensitive or resistant to pentavalent antimony. Intraperitoneal administration of the extract, into mice or hamsters that had been infected 2 months previously, led to antileishmanial T-cell proliferation among splenic mononuclear cells, the generation of host-protective cytokines (interferon-gamma, tumour necrosis factor and interleukin-12) and the upregulation of the expression of inducible nitric oxide synthase (and subsequent NO generation) in splenocytes. Furthermore, splenic macrophages from the HPE-treated mice showed increased generation of reactive oxygen species and enhanced surface expression of antigens of major histocompatibility complex class II (MHCII), and the extract restored the otherwise-defective antigen-presenting ability of the macrophages. Thus, in mice and hamsters infected with L. donovani, HPE therapy can stimulate both arms of the host's immune system and favour the complete resolution of the leishmanial infection. Among five human cases of visceral leishmaniasis, 30 daily intramuscular injections of HPE, at doses much lower than those used in the experimental infections, also gave very promising results. Based on the results of this pilot study, a further evaluation of the efficacy of HPE therapy, which may offer a cost-effective way of improving the treatment of antimony-resistant cases of visceral leishmaniasis, is being undertaken.

Item Type:	Article
Additional Information:	Copyright of this article belongs to Ingenta.
Subjects:	R Medicine > RS Pharmacy and materia medica
Depositing User:	Dr. K.P.S.Sengar
Date Deposited:	21 Feb 2012 18:05
Last Modified:	22 Jul 2015 10:29
URI:	http://crdd.osdd.net/open/id/eprint/1080

Actions (login required)

View Item